Taheri Leila, Boroujeni Ali Zargham, Kargar Jahromi Marzieh, Charkhandaz Maryam, Hojat Mohsen
Jahrom University of Medical Sciences, Jahrom, Iran.
Glob J Health Sci. 2015 Jan 1;7(4):184-9. doi: 10.5539/gjhs.v7n4p184.
Emergency treatment of patients with acute myocardial infarction is very important. Streptokinase in Iran is often as the only clot-busting medication is used. The purpose of using streptokinase medication is to revive the ischemic heart tissue, although has dangerous complications too. Therefore, the present study aimed to determine the effect of streptokinase on reperfusion after acute myocardial infarction and its complications, has been designed and conducted.
MATERIALS & METHODS: This is an Ex-post facto study. The study population included patients who suffer from acute myocardial infarction. The sample size was 300 patients, and 2 groups were matched, in variables of age, sex, underlying disease, frequencies and area of MI. Data collection did by researcher making questionnaire, that accept face and content validity by 10 expert researcher, the reliability was conducted with Spearman's test (r=0.85) by Test-retest method. Data analysis did by SPSS software: V 12.
Mean of EF in SK group was (46.15±8.11) and in control group was (43.11±12.57). Significant relationship was seen between SK, arrhythmia occurring and improve EF reperfusion by chi-square test (p=0.028), (p=0.020).The most arrhythmia in SK group was Ventricular Tachycardia (20.7%). Significant statistical relation between SK and mortality were found by Chi-square test (p=0.001). But a meaningful statistical relation was not found between SK and pulmonary edema incidence (p=0.071).
Nurses of CCU should be aware about SK complications such as hypotension, bleeding and arrhythmias. Proposed compare SK and tissue plasminogen drug in reperfusion and complications effect.
急性心肌梗死患者的急诊治疗非常重要。在伊朗,链激酶常作为唯一的溶栓药物使用。使用链激酶药物的目的是使缺血的心脏组织恢复活力,不过它也有危险的并发症。因此,本研究旨在确定链激酶对急性心肌梗死后再灌注及其并发症的影响,并已进行设计和实施。
这是一项事后回顾性研究。研究人群包括急性心肌梗死患者。样本量为300例患者,两组在年龄、性别、基础疾病、心肌梗死的频率和面积等变量上进行了匹配。数据收集由研究人员编制问卷进行,该问卷经10位专家研究人员进行了表面效度和内容效度评估,通过重测法用Spearman检验(r = 0.85)进行了信度检验。数据分析使用SPSS软件:V 12。
链激酶组的射血分数平均值为(46.15±8.11),对照组为(43.11±12.57)。通过卡方检验发现链激酶与心律失常的发生以及射血分数再灌注改善之间存在显著关系(p = 0.028),(p = 0.020)。链激酶组中最常见的心律失常是室性心动过速(20.7%)。通过卡方检验发现链激酶与死亡率之间存在显著的统计学关系(p = 0.001)。但未发现链激酶与肺水肿发生率之间有有意义的统计学关系(p = 0.071)。
冠心病重症监护病房的护士应了解链激酶的并发症,如低血压、出血和心律失常。建议比较链激酶和组织纤溶酶原药物在再灌注及并发症影响方面的情况。